BNP Paribas’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Sell |
8,461
-1,025
| -11% | -$17.2K | ﹤0.01% | 238 |
|
|
2025
Q1 | $146K | Sell |
9,486
-3,169
| -25% | -$48.7K | 0.01% | 240 |
|
|
2024
Q4 | $279K | Buy |
12,655
+4,737
| +60% | +$104K | ﹤0.01% | 244 |
|
|
2024
Q3 | $143K | Buy |
7,918
+7,218
| +1,031% | +$130K | 0.01% | 243 |
|
|
2024
Q2 | $11.4K | Sell |
700
-969
| -58% | -$15.7K | ﹤0.01% | 290 |
|
|
2024
Q1 | $23.5K | Buy |
+1,669
| New | +$23.5K | ﹤0.01% | 285 |
|